Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart Failure

NCT00521820 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
518
Enrollment
INDUSTRY
Sponsor class

Stopped Higher incidence of hospitalization for congestive heart failure in pioglitazone-treated subjects compared to glyburide treated subjects.

Conditions

Interventions

Sponsor

Takeda